154 related articles for article (PubMed ID: 10503163)
1. Polycystic ovary syndrome--searching for an animal model.
Szukiewicz D; Uilenbroek JT
J Med; 1998; 29(5-6):259-75. PubMed ID: 10503163
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovarian disease: animal models.
Mahajan DK
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):705-32. PubMed ID: 2973982
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
4. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
5. Ovarian expression of alpha (1)- and beta (2)-adrenoceptors and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries.
Manni L; Holmäng A; Lundeberg T; Aloe L; Stener-Victorin E
Auton Neurosci; 2005 Mar; 118(1-2):79-87. PubMed ID: 15795180
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid fails to induce polycystic ovary syndrome in female rats.
Lagace DC; Nachtigal MW
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):587-94. PubMed ID: 12787843
[TBL] [Abstract][Full Text] [Related]
7. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
Franks S; McCarthy MI; Hardy K
Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
[TBL] [Abstract][Full Text] [Related]
8. Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
Zhu JQ; Zhu L; Liang XW; Xing FQ; Schatten H; Sun QY
Mol Hum Reprod; 2010 Apr; 16(4):260-6. PubMed ID: 19828691
[TBL] [Abstract][Full Text] [Related]
9. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome: etiology and pathogenesis.
Matalliotakis I; Kourtis A; Koukoura O; Panidis D
Arch Gynecol Obstet; 2006 Jul; 274(4):187-97. PubMed ID: 16685527
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
12. [Modeling of the polycystic ovary syndrome].
Chebotareva IuIu; Ovsiannikov VG
Patol Fiziol Eksp Ter; 2009; (3):29-31. PubMed ID: 19919014
[TBL] [Abstract][Full Text] [Related]
13. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
14. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk.
Shi D; Vine DF
Fertil Steril; 2012 Jul; 98(1):185-93. PubMed ID: 22607890
[TBL] [Abstract][Full Text] [Related]
15. Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence.
Stener-Victorin E; Jedel E; Mannerås L
J Neuroendocrinol; 2008 Mar; 20(3):290-8. PubMed ID: 18047551
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome in adolescents.
Franks S
Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
18. Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome.
Hendriks ML; Ket JC; Hompes PG; Homburg R; Lambalk CB
Hum Reprod Update; 2007; 13(3):249-64. PubMed ID: 17208949
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats.
Honnma H; Endo T; Henmi H; Nagasawa K; Baba T; Yamazaki K; Kitajima Y; Hayashi T; Manase K; Saito T
Apoptosis; 2006 Sep; 11(9):1525-33. PubMed ID: 16820958
[TBL] [Abstract][Full Text] [Related]
20. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
